StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
2
Publishing Date
2024 - 03 - 28
3
2024 - 03 - 18
3
2024 - 02 - 22
3
2024 - 02 - 12
4
2023 - 12 - 22
4
2023 - 12 - 12
3
2023 - 10 - 31
3
2023 - 10 - 17
3
2023 - 09 - 26
3
2023 - 09 - 22
4
2023 - 06 - 08
3
2023 - 05 - 30
3
2023 - 05 - 01
3
2023 - 04 - 05
3
2023 - 02 - 02
3
2023 - 01 - 27
3
2022 - 08 - 10
3
2022 - 06 - 06
3
2022 - 06 - 03
3
2022 - 06 - 02
3
2022 - 04 - 12
4
2022 - 04 - 05
3
2022 - 02 - 25
3
2021 - 11 - 12
3
2021 - 11 - 03
3
2021 - 10 - 01
3
2021 - 09 - 17
3
2021 - 09 - 16
3
2021 - 09 - 08
3
2021 - 08 - 19
3
2021 - 07 - 30
3
2021 - 07 - 09
3
2021 - 06 - 25
3
2021 - 06 - 17
3
2021 - 06 - 10
5
2021 - 06 - 04
3
2021 - 05 - 24
3
2021 - 05 - 20
5
2021 - 05 - 19
3
2021 - 05 - 18
4
2021 - 05 - 12
3
2021 - 05 - 05
2
2021 - 04 - 29
3
2021 - 04 - 28
4
2021 - 04 - 23
5
2021 - 04 - 22
2
2021 - 04 - 16
4
2021 - 04 - 14
3
2021 - 04 - 13
3
2021 - 04 - 12
2
2021 - 04 - 07
3
2021 - 03 - 25
2
2021 - 03 - 19
3
2021 - 03 - 11
2
2021 - 03 - 04
2
2021 - 01 - 20
2
2021 - 01 - 11
2
2021 - 01 - 04
2
2020 - 12 - 11
3
2020 - 12 - 08
2
Sector
Health technology
2
Tags
Approval
1
Cancer
1
Colorectal cancer
1
Europe
1
Glioblastoma
1
N/a
1
Nivolumab
1
Pharmaceutical
1
Rosa
1
Satellite
1
Therapy
1
Treatment
2
Entities
Anavex life sciences corp.
1
Bristol-myers squibb company
2
Clovis oncology, inc.
1
Cns pharmaceuticals, inc.
1
Intellia therapeutics, inc.
1
Regeneron pharmaceuticals, inc.
1
Symbols
AAPL
4
ABB
4
ABBV
3
AKYA
2
AMCR
2
AMCX
2
APO
2
ARVL
7
AVY
2
BDX
2
BEEM
2
BIIB
2
BIVI
2
BLK
2
BMY
2
CERE
2
CNSP
3
CNXC
3
CP
2
CPRX
2
CSCO
4
DHR
2
DRE
2
ERIC
3
EVOK
2
EXTR
2
FRBA
2
GE
2
GM
2
GOLD
3
GOOG
2
GOOGL
2
GSK
2
HON
3
HUBS
4
INM
2
INTC
2
IOVA
2
JNJ
6
KAR
2
LLY
6
LMPX
2
MAR
2
MDT
2
MDWD
3
MGM
2
MIDD
27
MMM
2
MRNA
2
MS
10
NEM
2
NG
2
NOC
2
NTLA
2
NYMT
2
OOMA
2
SAN
6
SNY
5
TRU
4
VCEL
3
Exchanges
Nasdaq
1
Nyse
2
Crawled Date
2021 - 06 - 29
2
Crawled Time
12:15
1
13:00
1
Source
www.biospace.com
1
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 06 - 29
symbols :
Bmy
save search
Global Glioblastoma Multiforme (GBM) Treatment Market Could Reach Nearly $1.8 Billion By 2027
Published:
2021-06-29
(Crawled : 13:00)
- prnewswire.com
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-26.31%
|
O:
0.0%
H:
0.32%
C:
-0.2%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
65.25%
|
O:
-0.08%
H:
1.06%
C:
0.68%
NTLA
|
$21.57
1.17%
1.16%
1.4M
|
Health Technology
|
-83.83%
|
O:
-2.19%
H:
17.95%
C:
16.17%
CNSP
|
$0.1934
-5.2%
-5.48%
87K
|
Health Technology
|
-90.05%
|
O:
33.33%
H:
0.0%
C:
-20.52%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.61%
|
O:
0.81%
H:
0.0%
C:
-5.95%
AVXL
|
News
|
$3.8
0.0%
2.1M
|
Health Technology
|
-86.9%
|
O:
-0.59%
H:
0.17%
C:
-17.64%
treatment
glioblastoma
Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the Treatment of Mismatch Repair Deficient or Microsatellite Instability–High Metastatic Colorectal Cancer After Prior Chemotherapy
Published:
2021-06-29
(Crawled : 12:15)
- biospace.com/
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-26.31%
|
O:
0.0%
H:
0.32%
C:
-0.2%
satellite
treatment
rosa
europe
therapy
cancer
colorectal cancer
approval
nivolumab
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.